T cell vaccination in mice with invasive pulmonary aspergillosis.
about
Role of germination in murine airway CD8(+) T-cell responses to Aspergillus conidiaNew insights on the development of fungal vaccines: from immunity to recent challengesAdoptive T-cell therapy for fungal infections in haematology patientsAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisEarly NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.Innate immunity to Aspergillus species.The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis.Fungal antigens expressed during invasive aspergillosisRodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Chemically induced disseminated pythiosis in BALB/c mice: A new experimental model for Pythium insidiosum infection.Aspergillus infections in transplant recipients.Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia.Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosisKilling of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates.Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.Epidemiology and treatment approaches in management of invasive fungal infectionsVaccines for invasive fungal infectionsCytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?NADPH oxidase regulates efficacy of vaccination in aspergillosisManagement of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsCurrent approaches to diagnosis and treatment of invasive aspergillosis.Advances in combating fungal diseases: vaccines on the thresholdGenome-Wide Expression Profiling Reveals S100B as Biomarker for Invasive Aspergillosis.Respiratory dendritic cells: mediators of tolerance and immunity.Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut MicrobiomeCurrent and future therapeutic options in the management of invasive aspergillosis.Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.In silico Identification of Potential Peptides or Allergen Shot Candidates Against Aspergillus fumigatusImmunotherapy for opportunistic infections: Current status and future perspectives.Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals.T-cell Subsets and Antifungal Host DefensesImmune responses against Aspergillus fumigatus: what have we learned?T cell immunity and vaccines against invasive fungal diseases.Cytokines and the regulation of fungus-specific CD4 T cell differentiation.Immunotherapy against invasive mold infections.Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.
P2860
Q23921895-9CBEA852-D3E6-47C2-9BA0-D905D4BDD7A2Q26776056-A0D738A3-BF05-48DA-97B7-9CB31B67D12BQ26781064-4214A618-9B21-4A97-9FEA-DBD2F94A2B97Q28818603-949150B6-A7AF-4771-8038-3ABF4C462C5CQ30433397-F2D51284-F929-47D3-A079-CD17280B8B4DQ30434628-B670DE28-F6C4-4199-A9A5-C88CEC93218AQ30441625-1FAFD21C-07FF-4C22-B603-F2D1E8316B9CQ33220252-82E1E754-FC0A-418E-BF7E-54C6091B89EBQ33689767-CB7C72FD-CCF3-4BE8-9A60-B389489D681CQ33707923-11D23922-3B26-49DF-9DEF-A08384C3E47EQ33719294-0CB8C37F-04B4-4063-A7AE-5A401C1A36FBQ33788735-5D90A5DA-E151-449E-9C1F-C43181EBAEFFQ33828598-DEDE1121-33A7-4453-B230-817280DAAB14Q34111786-6B8630E1-9CCA-423F-B94A-6198B91131B1Q34111903-66AF12B9-4E63-4BF2-983F-13DC6DCACCB2Q35011464-E1C90811-E623-453D-B62F-9452350A775FQ35073715-D4E54C0D-9F1B-4343-BAC9-A9FD565AB945Q35089772-5A2FEDAB-D7B1-456B-85AB-1B25BABD76B1Q35161720-8A6FAADF-0C4C-4D23-9BAE-FE72350AE4EBQ35591125-F72AD200-05C4-48BF-9551-379F4D9A9D21Q35913774-1A7A1A85-4967-4E6E-803C-15892BB47ED8Q36087577-C78F262F-F3B2-47CB-8680-0D78EA7058A5Q36357893-ED194CB1-76D7-4505-8AFB-78B714F68AA2Q36406460-2548F722-5C7A-4BC8-8080-68EC96F7BE9BQ36707560-707C73B4-A767-4F00-BA23-FF0A27A6B412Q36961058-C42746B6-F1A9-4C8A-9547-11D20BC0D50FQ37018586-0134B988-841D-4F04-A7C4-D4C7C6922B85Q37079099-F2513622-A16F-4217-ACF7-4180E4E86B12Q37132306-AB002942-D3D7-4628-9A2C-906350218673Q37373457-4335259D-615A-4E51-962F-581B01D52ABBQ37424930-363BB481-9C20-4DE7-A8B7-89B0FCF77993Q37509216-E1D1143F-5A35-462D-A477-396D19EDE89AQ37598729-435CDD36-1B8C-45F9-BDB4-5DE0BF490B97Q37803134-F1C3D14A-80B0-4B14-B2B4-91CD72DEB0F6Q37888393-DF488E65-E7ED-48B4-8A7B-545EA76C130EQ37911513-1A7A3966-81E2-45B8-9D62-64803ED40FCDQ37963574-C1079625-B587-40E4-A258-B8F6286E2B7FQ37965757-C25D9257-0C15-40DB-A9AF-BF3A57719C2AQ37990413-3DC84E24-727F-4C48-B967-7E4B251F11E6Q38067451-61E4F1C9-B988-4D4E-994D-01B457981B2D
P2860
T cell vaccination in mice with invasive pulmonary aspergillosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
T cell vaccination in mice with invasive pulmonary aspergillosis.
@en
T cell vaccination in mice with invasive pulmonary aspergillosis.
@nl
type
label
T cell vaccination in mice with invasive pulmonary aspergillosis.
@en
T cell vaccination in mice with invasive pulmonary aspergillosis.
@nl
prefLabel
T cell vaccination in mice with invasive pulmonary aspergillosis.
@en
T cell vaccination in mice with invasive pulmonary aspergillosis.
@nl
P2093
P50
P1476
T cell vaccination in mice with invasive pulmonary aspergillosis
@en
P2093
P304
P356
10.4049/JIMMUNOL.165.1.381
P407
P577
2000-07-01T00:00:00Z